Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 111.68M P/E - EPS this Y 40.50% Ern Qtrly Grth -
Income -49.76M Forward P/E 70.00 EPS next Y 83.10% 50D Avg Chg -18.00%
Sales 23.23M PEG - EPS past 5Y - 200D Avg Chg -52.00%
Dividend N/A Price/Book 0.49 EPS next 5Y - 52W High Chg -84.00%
Recommedations 2.00 Quick Ratio 2.03 Shares Outstanding 10.64M 52W Low Chg 7.00%
Insider Own 21.40% ROA -10.90% Shares Float 8.20M Beta -0.16
Inst Own 13.94% ROE -23.71% Shares Shorted/Prior 6.94K/27.51K Price 0.70
Gross Margin 48.02% Profit Margin -262.11% Avg. Volume 151,390 Target Price 9.00
Oper. Margin -142.81% Earnings Date - Volume 232,840 Change 1.45%
About Prenetics Global Limited

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes Insighta, a multi-cancer early detection technology. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests. Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. It operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.

Prenetics Global Limited News
12/19/24 Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
12/06/24 iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024
12/05/24 Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
12/04/24 Prenetics Announces Participation in December Investor Conferences
11/27/24 Prenetics Announces Third Quarter 2024 Financial Results
11/18/24 MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
11/18/24 Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
11/13/24 Prenetics Global And 2 Other US Penny Stocks To Watch
11/12/24 Sidoti Events, LLC's Virtual November Micro-Cap Conference
10/30/24 Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
10/15/24 Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
10/07/24 Prenetics Announces Second Quarter 2024 Financial Results
08/19/24 Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
07/11/24 Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
07/01/24 Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
06/30/24 We Think Prenetics Global (NASDAQ:PRE) Can Afford To Drive Business Growth
06/18/24 Prenetics Announces First Quarter 2024 Financial Results